Sensitizing HR-proficient cancers to PARP inhibitors

Lignende værker

• COMPROMISED CDK1 ACTIVITY SENSITIZES BRCA-PROFICIENT CANCERS TO PARP INHIBITION
  af: Johnson, Neil, et al.
  Udgivet: (2011)
• CDK12 INHIBITION REVERSES DE NOVO AND ACQUIRED PARP INHIBITOR RESISTANCE IN BRCA WILD-TYPE AND MUTATED MODELS OF TRIPLE-NEGATIVE BREAST CANCER
  af: Johnson, Shawn F., et al.
  Udgivet: (2016)
• Repression of BET activity sensitizes homologous recombination–proficient cancers to PARP inhibition
  af: Yang, Lu, et al.
  Udgivet: (2017)
• Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer
  af: Angela Schab, et al.
  Udgivet: (2025-07-01)
• Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition
  af: Cruz, Olga Villamar, et al.
  Udgivet: (2016)